Research Overview

We focus on distinct cellular structures that mediate cell adhesion and contractility. Cell-matrix and cell-cell junctions and the actomyosin cytoskeleton are responsible for the dynamic control of cell and tissue shape during development and homeostasis and their mis-regulation is associated with various diseases.

Regulation of actomyosin contractility

Contractile tubes are a hallmark of many important animal organs, such as blood and lymphatic vessels, lung airways, mammary and salivary glands, and urinal and reproductive tracts. In larger tubular tissues, contractility is afforded by smooth muscle cells surrounding epithelial cells, and in smaller tubes the epithelial or endothelial cells themselves are contractile.

Actomyosin cytoskeleton in fibroblasts

The actomyosin network is essential for cellular functions such as migration and adhesion, where force generation and sensing are important properties. Parallel actomyosin stress fibers crosslinked by a-actinin can additionally be crosslinked by highly structured arrays of myosin, called myosin stacks, that form when myosin regions in neighboring stress fibers align with each other.

Cytoskeleton dynamics in embryogenesis

Embryogenesis comprises of serial, and on occasion simultaneous, occurrence of highly coordinated and regulated processes that lead to the formation of an organism. These processes are fairly conserved in all animal embryos. During embryogenesis, morphogenetic changes take place to bring about the formation of tissues from an initial mass of cells. 

Organ morphogenesis

All multicellular organisms embrace an intricate set of organs with unique architecture and functionality. Organogenesis, i.e. formation of an organ, involves a coordination of biochemical signals and mechanical cues. Although a significant advancement has been made in understanding the genetic regulation of different cell and tissue behaviors during 3D organ development, the role of mechanical force is only beginning to emerge.

Modeling of human disease in C. elegans

The decreasing cost of whole genome sequencing and the push toward personalized medicine is driving an exponential growth in the number of human patients who have their genomes sequenced. As a result, more than 80 million variations in the genome, including single nucleotide polymorphisms, insertions, deletions, and other structural variants have been identified.